(Press-News.org) New studies shared at the 2025 annual EULAR congress in Barcelona reinforce that position, highlighting the benefits that nurse-led care can bring for both patients and healthcare systems.
Nurse-led care and self-monitoring can both support treat-to-target (T2T) approaches.2,3 Combining self-monitoring with nurse support during the initiation of urate-lowering therapy in people with gout could help reduce physician visits and costs while maintaining or improving quality of care. Work shared by Jeffrey van der Ven looked at estimating the cost-effectiveness of nurse-led home monitoring of serum urate compared to usual management in secondary care using a decision-modelling approach. The modelled intervention involved specialised rheumatology nurses remotely supporting patients in stepwise dose adjustments using a T2T approach based on point-of-care testing for serum urate, which patients can perform at home. Usual care relied on the same T2T strategy with standard hospital-based laboratory measurements and routine rheumatologist visits. The findings showed home monitoring was cost-effective with a mean incremental net monetary benefit of €130. Improvements in health outcomes were modest, but compared to usual care the intervention saved time for rheumatologists due to task reallocation towards rheumatology nurses – with rheumatologists saving 42.7 minutes, while nurses spent an extra 51.2 minutes. This time saving could potentially allow rheumatologists to see more new patients. Future studies should focus on ways to reduce the nurse time needed while maintaining adherence – and automated feedback and risk stratification based on home monitored values might be a promising next step.
A clinic in the UK has been experimenting with using nurses to speed the time to biologic initiation for patients with inflammatory arthritis. Theresa May presenting findings from a weekly biologic group education clinic led by an experienced nurse practitioner – in place of individual face-to-face appointments. Each clinic has two groups of 3–4 patients, grouped according to the class of biologics. In a group appointment over 30 minutes, patients are informed of treatment benefits, risks and side effects, administration, and monitoring. A quality improvement project and audit included 28 patients, and showed that waiting times from treatment decision to the education appointment improved from 46 to 10 days after implementation of group education clinics. The weekly clinic capacity for biologic education has increased from 6 to 12–18 patients per clinic, with minimal impact on administrative burden. All patients reported that they found the sessions useful, interactive, and engaging, and were happy with the format – in particular the opportunity for peer support. When asked to score out of 10 (10=best), patients gave the overall quality of the session 9.85, and rated their confidence about biologic knowledge after the session as 9.42. The authors conclude that nurse-led biologic group education clinics are a feasible and effective intervention for reducing waiting times for patients starting biologic therapy, and can improve patient satisfaction.
Source
van der Ven J, et al. Cost-effectiveness of nurse-led home monitoring of serum uric acid values for gout patients in secondary care: a modelling study. Presented at EULAR 2025; OP0303.
Ann Rheum Dis 2025; DOI: 10.1136/annrheumdis-2025-eular.B3248.
Alcala TM, et al. Nurse-led Biologic Group Education Clinic for patients with inflammatory arthritis: A Quality Improvement Project. Presented at EULAR 2025; OP0118-HPR.
Ann Rheum Dis 2025; DOI: 10.1136/annrheumdis-2025-eular.C138.
References
1. Bech B, et al. 2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. Ann Rheum Dis 2020;79:61–8. DOI: 10.1136/annrheumdis-2019-215458.
2. Doherty M, et al. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial. Lancet 2018;392(10156):1403–12. DOI: 10.1016/S0140-6736(18)32158-5.
3. Riches PL, et al. Evaluation of supported self-management in gout (GoutSMART): a randomised controlled feasibility trial. Lancet Rheumatol 2022;4(5):e320–8. DOI: 10.1016/S2665-9913(22)00062-5.
About EULAR
EULAR is the European umbrella organisation representing scientific societies, health professional associations and organisations for people with rheumatic and musculoskeletal diseases (RMDs). EULAR aims to reduce the impact of RMDs on individuals and society, as well as improve RMD treatments, prevention, and rehabilitation. To this end, EULAR fosters excellence in rheumatology education and research, promotes the translation of research advances into daily care, and advocates for the recognition of the needs of those living with RMDs by EU institutions.
Contact
EULAR Communications, communications@eular.org
END
Nurses: A critical role for people with RMD
2025-06-13
ELSE PRESS RELEASES FROM THIS DATE:
Online information for patients needs guidance
2025-06-13
Recommendations stress that communication impacts treatment outcomes and shared decision-making between patients and physicians. Health literacy is an important aspect in this regard, and a person’s understanding of their condition can impact how they are able to use health information.2 There is growing evidence to suggest that internet-based information is an important tool for improving communication with healthcare professionals – and for many patients it plays a central role in their experience.3
New work presented at the 2025 annual EULAR ...
The many ways that AI enters rheumatology
2025-06-13
High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential to improve the quantification and characterisation of SSc-ILD, making it a powerful tool for monitoring. Francesca Motta offered new data from an observational study pitting AI-assisted analysis against two radiologists with expertise in thoracic imaging. Results showed that the AI outperformed visual scoring in assessing the progression of fibrosis in patients with SSc-ILD, and showed more significant correlation with values from pulmonary ...
Pregnancy outcomes in autoinflammatory disease
2025-06-13
To address this, a French multi-centre prospective pregnancy observational cohort was set up, to analyse disease activity, treatment, pregnancy outcomes, delivery, and neonatal health. The work – presented at the 2025 annual congress of EULAR – showcased findings from 97 women with an autoinflammatory disease. The most common diagnoses were FMF (81%), followed by undifferentiated systemic autoinflammatory diseases (USAID), tumour necrosis factor receptor-associated periodic syndrome (TRAPS), cryopyrin-associated periodic syndromes (CAPS), Still's disease, recurrent pericarditis, mevalonate kinase deficiency, A20 haploinsufficiency, and other ...
The value of physical activity for people with RMD
2025-06-13
Several sessions at the 2025 annual congress of EULAR, which took place in Barcelona, focused on the value of physical activity for people with a variety of RMD – as well as the potential barriers to implementing these programs in the real world.
Previous trials have demonstrated that long-standing, personalised supervised exercise therapy is more effective than usual care after 1 year in people with severe functional limitations due to rheumatoid arthritis (RA) or axial spondyloarthritis (axSpA).3,4 David Ueckert and colleagues set out to evaluate ...
First data from the EULAR RheumaFacts project
2025-06-13
New work presented at the 2025 congress of EULAR – The European Alliance of Associations for Rheumatology – in Barcelona described RMD health-related indicators from all EULAR member countries, collected as part of the RheumaFacts project – a study identifying potential inequities between countries.
Data were collected on a diverse range of topics, including access to reimbursed physiotherapy and psychological care, the possibility for patients to self-refer to rheumatologists in the public sector, the number of rheumatology departments and rheumatologists, and treatment availability. So far, 31 countries have submitted data.
The ...
Research spotlight: Preventing stalling to improve CAR-T cells’ efficacy against tumors
2025-06-13
Marcela Maus, MD, PhD, director of the Cellular Immunotherapy Program and the Paula J. O'Keeffe Endowed Chair of the Mass General Cancer Center, is senior author and Stefanie Bailey, PhD, Hana Takei, and Giulia Escobar, PhD of the Krantz Family Center for Cancer Research at Massachusetts General Hospital are co-lead authors of a paper published in Science Translational Medicine, “IFN-g-resistant CD28 CAR-T cells demonstrate increased survival, efficacy, and durability in multiple murine ...
c-Fos expression differentially acts in the healthy brain compared with Alzheimer’s disease
2025-06-13
Immediate-early genes (IEGs), including c-Fos, are integral to the brain's response to stimuli. Initially identified as a proto-oncogene, c-Fos is essential for neural activity, synaptic plasticity, and stress responses. While its transient expression supports memory formation in healthy brains, chronic overexpression in AD exacerbates neurotoxicity and cognitive decline. This review synthesizes findings from postmortem studies, animal models, and cell cultures to elucidate the dual roles of c-Fos and its mechanisms in AD pathogenesis.
Expression of c-Fos in Brain Regions and Cell Types
c-Fos is expressed in specific brain regions such as the hippocampus, amygdala, and cortex, ...
Computed tomography perfusion and angiography for death by neurologic criteria
2025-06-13
About The Study: The observed sensitivity and specificity measures for computed tomography perfusion and computed tomography angiography as an ancillary test for death by neurologic criteria did not meet the prespecified validation threshold of greater than 98%. Clinical examination remains the cornerstone of death by neurologic criteria, and ancillary imaging should be interpreted cautiously within a comprehensive clinical assessment.
Corresponding Author: To contact the corresponding author, Michael Chasse, MD, PhD, email michael.chasse@umontreal.ca.
To access ...
New tool could help Florida homeowners weather flood risks, lower insurance costs
2025-06-13
With flood risks increasing from extreme weather events like hurricanes and even routine plumbing issues, a team from the University of Florida’s College of Design, Construction and Planning is helping Florida homeowners make smarter choices about building materials and interior finishes that better protect their homes and potentially save on their insurance premiums.
Lisa Platt, Ph.D., an assistant professor in the department of interior design and a researcher within the Florida Institute for Built Environment Resilience, or FIBER, and Arezoo Zeinali, a graduate research assistant in Platt’s Design Dynamics ...
Researchers develop a rapid method for building vascular organoids
2025-06-13
Blood vessels are essential to nearly all tissues, delivering nutrients and oxygen, regulating hemostasis, and modulating inflammation. Recreating functional vascular networks is foundational to both basic and translational vascular biology, however current methods to make blood vessels from stem cells are often slow, inefficient, or lack the complexity needed for therapy.
In this study, researchers developed a fast and defined method to build vascular organoids—3D microvascular networks—from human stem cells. By ...